About company
Developer of a point-of-care patient screening platform designed to detect Staphylococcus aureus and a broad panel of dangerous and evolving pathogens. The company's patient screening platform has the potential to fundamentally alter the market for detecting dangerous pathogens through a panel of in-vitro diagnostics, enabling hospitals, nursing homes and other healthcare facilities to prevent the spread of disease causing organisms and significantly impact the clinical care of patients.
- US
- george.newcomb@saureus.com
- Unknown
- www.saureus.com/
- Not verified company
